U.S. Markets, Trends, and Opportunities in Patient Monitoring Products
U.S. Markets, Trends, and Opportunities in Patient Monitoring Products
$4,750.00
The intensity and high acuity of the critical care environment, combined with the shortage of experienced registered nurses, means that noninvasive and minimally invasive patient monitoring products will be in great demand during the forecast period covered by this report.
Publisher: Medtech Insight
- Description
- Contents
- Samples
Critical care in the United States (U.S.) is expanding rapidly, particularly as hospital lengths of stay decrease, and the intensity of care and acuity of patients admitted to hospitals increase. Critical care provides care to patients with life-threatening conditions. The more critically ill the patient, the more likely he or she is to have highly complex and unstable symptoms requiring intensive care. The intensity and high acuity of the critical care environment, combined with the shortage of experienced registered nurses, means that noninvasive and minimally invasive patient monitoring products will be in great demand during the forecast period covered by this report, particularly those that provide memory storage, remote access, smart alarms, wireless capabilities, and other advanced features.
Table of Contents
1. OVERVIEW OF CRITICAL CARE……………………………………………………… 1-1
1.1 Critical Care Staff …………………………………………………………………… 1-3
1.1.1 Intensivists………………………………………………………………. 1-3
1.1.2 Hospitalists……………………………………………………………… 1-4
1.1.3 Nurses……………………………………………………………………. 1-5
1.2 Critical Care Units…………………………………………………………………… 1-5
1.3 Emergency Departments…………………………………………………………. 1-8
1.4 Products and Equipment …………………………………………………………. 1-8
1.4.1 Invasive ………………………………………………………………….. 1-9
1.4.2 Noninvasive…………………………………………………………….. 1-9
1.4.3 Transport………………………………………………………………. 1-10
1.4.4 Medical Equipment Malfunctions………………………………. 1-10
1.5 Procedures Performed in the Intensive Care Unit ……………………… 1-12
1.6 Critical Access Hospital Designation ……………………………………….. 1-12
1.7 The Leapfrog Group ……………………………………………………………… 1-13
1.8 Healthcare Economics…………………………………………………………… 1-13
1.9 Demographics ……………………………………………………………………… 1-14
1.10 Managed Care……………………………………………………………………… 1-14
1.11 Mergers and Acquisitions ………………………………………………………. 1-18
1.12 Healthcare Worker Shortage ………………………………………………….. 1-18
1.12.1 Physician Shortage ………………………………………………… 1-19
1.12.2 Nursing Shortage …………………………………………………… 1-19
1.13 Group Purchasing Organizations ……………………………………………. 1-20
Exhibit 1-1: Critical Care Nursing Responsibilities………………………………………… 1-6
Exhibit 1-2: Community Hospitals in the United States, 2002-2012 ………………… 1-7
Exhibit 1-3: 2011, Personal Healthcare Service and Supply Expenditures
in the United States, by Category……………………………………………. 1-15
Exhibit 1-4: Population Forecast, by Age, 2010, 2020, and 2030………………….. 1-16
2. NEUROLOGIC MONITORING SYSTEMS MARKET ……………………………. 2-1
2.1 Clinical Overview……………………………………………………………………. 2-1
2.1.1 Traumatic Brain Injury ………………………………………………. 2-1
2.1.2 Stroke…………………………………………………………………….. 2-2
2.1.3 Cerebral Aneurysm ………………………………………………….. 2-3
2.1.4 Brain Tumors…………………………………………………………… 2-4
2.2 Intracranial Pressure Monitoring……………………………………………….. 2-5
2.2.1 Products and Technologies……………………………………….. 2-6
2.2.2 Market Analysis ……………………………………………………….. 2-8
2.2.3 Competitive Analysis ………………………………………………… 2-9
2.3 Cerebral Oximetry ………………………………………………………………….. 2-9
2.3.1 Products and Technologies……………………………………… 2-12
2.3.2 Market Analysis ……………………………………………………… 2-15
2.3.3 Competitive Analysis ………………………………………………. 2-17
2.4 Combined Market Analysis…………………………………………………….. 2-19
Exhibit 2-1: 2013, Selected Intracranial Pressure Monitoring Systems ……………. 2-7
Exhibit 2-2: Intracranial Pressure Monitoring Products, Market Forecast,
2012-2017 …………………………………………………………………………… 2-10
Exhibit 2-3: 2012, Intracranial Pressure Monitoring Products Market,
Share by Supplier…………………………………………………………………. 2-11
Exhibit 2-4: 2013, Selected Noninvasive Cerebral Oximetry Products…………… 2-16
Exhibit 2-5: Noninvasive Cerebral Oximetry Monitoring Products,
Market Forecast, 2012-2017 ………………………………………………….. 2-18
Exhibit 2-6: 2012, Noninvasive Cerebral Oximetry Products Market,
Share by Supplier…………………………………………………………………. 2-20
Exhibit 2-7: Neurologic Monitoring Systems, Combined Market Forecast,
2012-2017 …………………………………………………………………………… 2-21
3. BRAIN FUNCTION MONITORING PRODUCTS MARKET ……………………. 3-1
3.1 Intraoperative Awareness………………………………………………………… 3-1
3.2 Anesthesia Monitoring…………………………………………………………….. 3-3
3.3 Sedation Management ……………………………………………………………. 3-4
3.4 Cerebral Ischemia Monitoring…………………………………………………… 3-5
3.5 Costs ……………………………………………………………………………………. 3-5
3.6 Products and Technologies ……………………………………………………… 3-6
3.6.1 Covidien …………………………………………………………………. 3-6
3.6.2 Danmeter/Goalwick Holdings …………………………………….. 3-8
3.6.3 GE Healthcare/General Electric …………………………………. 3-8
3.6.4 Masimo…………………………………………………………………… 3-9
3.6.5 Medical Device Management …………………………………….. 3-9
3.6.6 Stryker……………………………………………………………………. 3-9
3.7 Market Analysis ……………………………………………………………………. 3-10
3.7.1 Market Drivers ……………………………………………………….. 3-10
3.7.2 Market Limiters………………………………………………………. 3-14
3.7.3 Market Forecast …………………………………………………….. 3-16
3.7.4 Competitive Analysis ………………………………………………. 3-16
Exhibit 3-1: 2013, Selected Brain Function Monitors and Sensors………………… 3-11
Exhibit 3-2: 2013, Healthcare Settings and Clinical Applications for
Brain Function Monitoring Products…………………………………………. 3-15
Exhibit 3-3: Brain Function Monitoring Products, Market Forecast,
2012-2017 …………………………………………………………………………… 3-17
Exhibit 3-4: 2012, Brain Function Monitoring Systems Market,
Share by Supplier…………………………………………………………………. 3-18
4. HEMODYNAMIC MONITORING PRODUCTS MARKET ………………………. 4-1
4.1 Pulmonary Artery Catheters …………………………………………………….. 4-1
4.1.1 Indications for Use……………………………………………………. 4-3
4.1.2 Utilization Debate …………………………………………………….. 4-4
4.1.3 Products and Technology………………………………………….. 4-5
4.1.3.1 Argon Medical Devices/
RoundTable Healthcare Partners…………………. 4-6
4.1.3.2 Arrow International/Teleflex…………………………. 4-6
4.1.3.3 Biosensors International……………………………… 4-6
4.1.3.4 Edwards Lifesciences…………………………………. 4-6
4.1.3.5 ICU Medical………………………………………………. 4-7
4.1.4 Market Analysis ……………………………………………………….. 4-7
4.1.5 Competitive Analysis ………………………………………………. 4-11
4.2 Noninvasive and Minimally Invasive Cardiac Output Monitoring ….. 4-11
4.2.1 Bioimpedance………………………………………………………… 4-11
4.2.2 Doppler Ultrasound ………………………………………………… 4-14
4.2.3 Fick Partial Rebreathing ………………………………………….. 4-16
4.2.4 Arterial Waveform Analysis ……………………………………… 4-16
4.2.5 Products and Technology………………………………………… 4-16
4.2.5.1 Cardiotronic/Osypka Medical……………………… 4-16
4.2.5.2 Cheetah Medical ……………………………………… 4-17
4.2.5.3 Deltex Medical…………………………………………. 4-17
4.2.5.4 Edwards Lifesciences……………………………….. 4-18
4.2.5.5 Fujifilm SonoSite/Fujifilm Holdings ……………… 4-18
4.2.5.6 Hemo Sapiens…………………………………………. 4-18
4.2.5.7 Innovision ……………………………………………….. 4-19
4.2.5.8 LiDCO ……………………………………………………. 4-19
4.2.5.9 Noninvasive Medical Technologies …………….. 4-19
4.2.5.10 Philips Healthcare/Royal Philips…………………. 4-20
4.2.5.11 Pulsion Medical Systems ………………………….. 4-20
4.2.5.12 Uscom ……………………………………………………. 4-20
4.2.6 Market Analysis ……………………………………………………… 4-24
4.2.7 Competitive Analysis ………………………………………………. 4-25
4.3 Combined Market Analysis…………………………………………………….. 4-25
Exhibit 4-1: 2013, Selected Pulmonary Artery Catheters ………………………………. 4-8
Exhibit 4-2: Pulmonary Artery Catheters, Market Forecast, 2012-2017 …………. 4-12
Exhibit 4-3: 2012, Pulmonary Artery Catheters Market, Share by Supplier…….. 4-13
Exhibit 4-4: How Impedance Cardiography Works……………………………………… 4-15
Exhibit 4-5: 2013, Selected Noninvasive and Minimally Invasive
Cardiac Output Monitoring Systems………………………………………… 4-21
Exhibit 4-6: Noninvasive and Minimally Invasive Cardiac Output
Monitoring Systems, Market Forecast, 2012-2017 …………………….. 4-26
Exhibit 4-7: 2012, Noninvasive and Minimally Invasive Cardiac Output
Monitoring Systems Market, Share by Supplier…………………………. 4-27
Exhibit 4-8: Hemodynamic Monitoring Products, Combined Market Forecast,
2012-2017 …………………………………………………………………………… 4-29
5. VITAL SIGNS MONITORING PRODUCTS MARKET …………………………… 5-1
5.1 Information Integration…………………………………………………………….. 5-2
5.2 Variable Acuity/Universal Beds ………………………………………………… 5-3
5.3 Connectivity…………………………………………………………………………… 5-4
5.4 Electronic Medical Records ……………………………………………………… 5-4
5.5 Patient Tagging ……………………………………………………………………… 5-5
5.6 Meaningful Use ……………………………………………………………………… 5-6
5.7 Health Level Seven Conformance…………………………………………….. 5-7
5.8 Wireless Medical Telemetry Service………………………………………….. 5-7
5.9 Mobile and Wireless Applications……………………………………………… 5-8
5.10 False Alarms ……………………………………………………………………….. 5-11
5.11 Vital Signs Monitoring Products, Market Analysis ……………………… 5-11
5.11.1 Modular Monitoring Systems……………………………………. 5-11
5.11.1.1 Products and Technology………………………….. 5-12
5.11.1.2 Market Forecast ………………………………………. 5-17
5.11.1.3 Competitive Analysis ………………………………… 5-22
5.11.2 Portable Monitoring Systems……………………………………. 5-24
5.11.2.1 Products and Technology………………………….. 5-27
5.11.2.2 Market Forecast ………………………………………. 5-36
5.11.2.3 Competitive Analysis ………………………………… 5-36
5.11.3 Telemetry Monitoring Systems …………………………………. 5-38
5.11.3.1 Products and Technology………………………….. 5-38
5.11.3.2 Market Forecast ………………………………………. 5-44
5.11.3.3 Competitive Analysis ………………………………… 5-47
5.11.4 Combined Market Analysis………………………………………. 5-49
Exhibit 5-1: Wireless Medical Telemetry Service and Related Bands ……………… 5-9
Exhibit 5-2: Selected Characteristics and Performance Requirements for
Adult Modular Vital Signs Monitoring Systems ………………………….. 5-13
Exhibit 5-3: Selected Characteristics and Performance Requirements for
Neonatal and Pediatric Modular Vital Signs Monitoring Systems …. 5-16
Exhibit 5-4: 2013, Selected Modular Vital Signs Monitoring Systems ……………. 5-18
Exhibit 5-5: Modular Vital Signs Monitoring Systems, Market Forecast,
2012-2017 …………………………………………………………………………… 5-23
Exhibit 5-6: 2012, Modular Vital Signs Monitoring Systems Market,
Share by Supplier…………………………………………………………………. 5-25
Exhibit 5-7: End-User Needs Supporting the Emergence of
Portable Vital Signs Monitoring Systems………………………………….. 5-26
Exhibit 5-8: Selected Characteristics and Performance Requirements for
Portable Vital Signs Monitoring Systems………………………………….. 5-28
Exhibit 5-9: 2013, Selected Portable Vital Signs Monitoring Systems……………. 5-30
Exhibit 5-10: Portable Vital Signs Monitoring Systems, Market Forecast,
2012-2017 …………………………………………………………………………… 5-37
Exhibit 5-11: 2012, Portable Vital Signs Monitoring Systems Market,
Share by Supplier…………………………………………………………………. 5-39
Exhibit 5-12: Selected Characteristics and Performance Requirements for
Telemetry Vital Signs Monitoring Systems ……………………………….. 5-40
Exhibit 5-13: 2013, Selected Telemetry Vital Signs Monitoring Systems …………. 5-45
Exhibit 5-14: Telemetry Vital Signs Monitoring Systems, Market Forecast,
2012-2017 …………………………………………………………………………… 5-48
Exhibit 5-15: 2012, Telemetry Vital Signs Monitoring Systems Market,
Share by Supplier…………………………………………………………………. 5-50
Exhibit 5-16: Vital Signs Monitoring Products, Combined Market Forecast,
2012-2017 …………………………………………………………………………… 5-51
6. COMPANY PROFILES…………………………………………………………………….. 6-1
6.1 CAS Medical Systems, Inc. ……………………………………………………… 6-1
6.2 Covidien LTD…………………………………………………………………………. 6-2
6.3 Dräger Medical, Inc./Drägerwerk AG & Co. KG…………………………… 6-5
6.4 Edwards Lifesciences Corporation ……………………………………………. 6-7
6.5 GE Healthcare/General Electric Company …………………………………. 6-8
6.6 ICU Medical, Inc. ……………………………………………………………………. 6-9
6.7 Integra LifeSciences Corporation ……………………………………………… 6-9
6.8 Johnson & Johnson………………………………………………………………. 6-10
6.9 Mindray Medical International LTD………………………………………….. 6-10
6.10 Philips Healthcare, Inc./Royal Philips NV …………………………………. 6-11
6.11 Spacelabs Healthcare/OSI Systems, Inc………………………………….. 6-13
6.12 Welch Allyn, Inc……………………………………………………………………. 6-14
APPENDIX: COMPANY LISTING……………………………………………………………… A-1
Figure: Neurologic Monitoring Systems, Market Forecast, 2012-2017
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Spain, Surgical Procedure Volumes 
Sign up to the